Because of this, we focus our research advocacy strategy on:
- Working with government, research funding bodies and diabetes organisations to influence their funding levels and priorities. We work in partnership to accelerate research funding and progress.
- We work with researchers to understand the research landscape, their needs and the barriers to progress and provide influence and funding to overcome them.
- We work with regulatory bodies to help to make new treatments and technologies available through the NHS as quickly as possible. We provide evidence and expertise from people with type 1 and research experts to the National Institute for Health and Care Excellence (NICE) and the Scottish Intercollegiate Guidelines Network (SIGN) when they review new treatment developments.